EP2114418A4 - Stabilized picoplatin oral dosage form - Google Patents

Stabilized picoplatin oral dosage form

Info

Publication number
EP2114418A4
EP2114418A4 EP08725393A EP08725393A EP2114418A4 EP 2114418 A4 EP2114418 A4 EP 2114418A4 EP 08725393 A EP08725393 A EP 08725393A EP 08725393 A EP08725393 A EP 08725393A EP 2114418 A4 EP2114418 A4 EP 2114418A4
Authority
EP
European Patent Office
Prior art keywords
dosage form
oral dosage
stabilized picoplatin
picoplatin oral
stabilized
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP08725393A
Other languages
German (de)
French (fr)
Other versions
EP2114418A1 (en
Inventor
Alistair J Leigh
Christopher A Procyshyn
Ernest S Y Wong
Christen M Giandomenico
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Genzyme Corp
Poniard Pharmaceuticals Inc
Original Assignee
Genzyme Corp
Poniard Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genzyme Corp, Poniard Pharmaceuticals Inc filed Critical Genzyme Corp
Publication of EP2114418A1 publication Critical patent/EP2114418A1/en
Publication of EP2114418A4 publication Critical patent/EP2114418A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/28—Compounds containing heavy metals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/243—Platinum; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/28—Mercury; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
EP08725393A 2007-02-09 2008-02-08 Stabilized picoplatin oral dosage form Withdrawn EP2114418A4 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US88917107P 2007-02-09 2007-02-09
US88968107P 2007-02-13 2007-02-13
PCT/US2008/001752 WO2008097661A1 (en) 2007-02-09 2008-02-08 Stabilized picoplatin oral dosage form

Publications (2)

Publication Number Publication Date
EP2114418A1 EP2114418A1 (en) 2009-11-11
EP2114418A4 true EP2114418A4 (en) 2013-01-09

Family

ID=39682046

Family Applications (1)

Application Number Title Priority Date Filing Date
EP08725393A Withdrawn EP2114418A4 (en) 2007-02-09 2008-02-08 Stabilized picoplatin oral dosage form

Country Status (12)

Country Link
EP (1) EP2114418A4 (en)
JP (1) JP2010518089A (en)
KR (1) KR20090109129A (en)
CN (2) CN104288119A (en)
AU (1) AU2008214202A1 (en)
BR (1) BRPI0806418A2 (en)
CA (1) CA2677640A1 (en)
HK (1) HK1206267A1 (en)
IL (1) IL200262A0 (en)
MX (1) MX2009008488A (en)
RU (1) RU2009133446A (en)
WO (1) WO2008097661A1 (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8173686B2 (en) 2006-11-06 2012-05-08 Poniard Pharmaceuticals, Inc. Use of picoplatin to treat colorectal cancer
US8168662B1 (en) 2006-11-06 2012-05-01 Poniard Pharmaceuticals, Inc. Use of picoplatin to treat colorectal cancer
US8178564B2 (en) 2006-11-06 2012-05-15 Poniard Pharmaceuticals, Inc. Use of picoplatin to treat colorectal cancer
US8168661B2 (en) 2006-11-06 2012-05-01 Poniard Pharmaceuticals, Inc. Use of picoplatin to treat colorectal cancer
EP2418955A4 (en) * 2009-04-15 2012-11-21 Poniard Pharmaceuticals Inc High bioavailability oral picoplatin anti-cancer therapy
AU2015263884B2 (en) * 2014-05-23 2019-11-14 Mingsight Pharmaceuticals, Inc. Treatment of autoimmune disease
CN107778331B (en) * 2016-08-27 2020-06-30 鲁南制药集团股份有限公司 Purification method of picoplatin
CN108864177B (en) * 2018-04-20 2020-07-28 公安部物证鉴定中心 [2H3]Synthesis method of (E) -1-methylamino-2-phenyl propane

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9502799D0 (en) * 1995-02-14 1995-04-05 Johnson Matthey Plc Improvements in platinum complexes
CN1434715A (en) * 2000-02-16 2003-08-06 山之内制药株式会社 Pharmaceutical compositions
US20030021854A1 (en) * 2001-04-23 2003-01-30 Burrell Robert Edward Method of induction of apoptosis and inhibition of matrix metalloproteinases using antimicrobial metals
DE10141528B4 (en) * 2001-08-24 2006-08-10 Faustus Forschungs Cie. Translational Cancer Research Gmbh Platinum (II) and platinum (IV) complexes and their use
US7691833B2 (en) * 2002-03-01 2010-04-06 Trustees Of Dartmouth College Compositions and methods for preventing sporadic neoplasia in colon
WO2004006859A2 (en) * 2002-07-16 2004-01-22 Sonus Pharmaceuticals, Inc. Platinum compound
AU2003302314A1 (en) * 2002-08-02 2004-07-09 Transave, Inc. Platinum aggregates and process for producing the same
JP2007529546A (en) * 2004-03-18 2007-10-25 トランセイブ， インク． Administration of cisplatin by inhalation
US20060205810A1 (en) * 2004-11-24 2006-09-14 Schering Corporation Platinum therapeutic combinations

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
No further relevant documents disclosed *

Also Published As

Publication number Publication date
HK1206267A1 (en) 2016-01-08
EP2114418A1 (en) 2009-11-11
WO2008097661A1 (en) 2008-08-14
RU2009133446A (en) 2011-03-20
JP2010518089A (en) 2010-05-27
CA2677640A1 (en) 2008-08-14
IL200262A0 (en) 2010-04-29
CN101678046A (en) 2010-03-24
AU2008214202A1 (en) 2008-08-14
KR20090109129A (en) 2009-10-19
MX2009008488A (en) 2010-01-15
CN104288119A (en) 2015-01-21
BRPI0806418A2 (en) 2011-09-06

Similar Documents

Publication Publication Date Title
IL251175A0 (en) Stabilized picoplatin dosage form
IL206159A0 (en) Oral pharmaceutical dosage forms
ZA201006029B (en) Pharmaceutical dosage form
EP2178893A4 (en) Oral formulations for picoplatin
ZA201005015B (en) Solid pharmaceutical dosage form
ZA201101523B (en) Linaclotide-containing formulations for oral administration
PL2077729T3 (en) Probiotic oral dosage forms
HK1154484A1 (en) Oral dosage composition
GB0710439D0 (en) Oral dosage form
HK1206267A1 (en) Stabilized picoplatin oral dosage form
IL205160A0 (en) Oral dosage forms comprising licarbazepine acetate
SI2167033T1 (en) Once daily oral dosage form comprising tacrolimus
EP2226071A4 (en) Composition for oral administration
ZA200903858B (en) Pharmaceutical dosage form
HK1137363A1 (en) Novel dosage form
GB0822124D0 (en) Oral dosage form
EP2337565A4 (en) Stable solid oral dosage co-formulations
ZA201102405B (en) Pharmaceutical composition for oral administration
HK1115054A1 (en) Preparation for oral administration
GB0704123D0 (en) Dosage form

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20090908

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MT NL NO PL PT RO SE SI SK TR

DAX Request for extension of the european patent (deleted)
A4 Supplementary search report drawn up and despatched

Effective date: 20121211

RIC1 Information provided on ipc code assigned before grant

Ipc: A01N 55/02 20060101ALI20121205BHEP

Ipc: A61K 33/24 20060101AFI20121205BHEP

Ipc: A61K 9/28 20060101ALI20121205BHEP

Ipc: A61K 31/28 20060101ALI20121205BHEP

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION HAS BEEN WITHDRAWN

18W Application withdrawn

Effective date: 20130905